Note: The following article synopsis was NOT provided by AAPC. It was created by Find-A-Code/innoviHealth.
Article Overview
This brief industry note highlights new HCPCS Level II additions announced by CMS and references a related MLN Matters update on Medicare claims reporting for compounded drugs. It is relevant for coders, billers, and reimbursement staff who track code-set changes and Medicare guidance affecting drug and biological claims.
Why This Topic Matters
New HCPCS codes and related CMS reporting updates can affect how claims are coded and submitted for drugs and biologicals, especially when effective dates and agency guidance change.
What You Will Learn
Which new HCPCS Level II codes CMS announced
The general timing of the code additions
That CMS linked the update to Medicare claims reporting guidance for compounded drugs
Where the article points readers for the underlying CMS notice
Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4800 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.
Related Articles
Articles are listed in order of calculated relevance.